Literature DB >> 7482639

Respiratory function and risk of stroke.

S G Wannamethee1, A G Shaper, S Ebrahim.   

Abstract

BACKGROUND AND
PURPOSE: This report examines the relationship between lung function and risk of major stroke events (fatal and nonfatal).
METHODS: We completed a prospective study of 7735 men aged 40 to 59 years at screening selected at random from one general practice in each of 24 British towns.
RESULTS: During the mean follow-up period of 14.8 years, there were 277 major stroke events in the 7650 men with data on forced expiratory volume in 1 second (FEV1). After exclusion of 499 men with definite myocardial infarction, stroke, or atrial fibrillation at screening, 7151 men experienced 239 major stroke events. Lower levels of FEV1 were associated with a significant increase in risk of stroke even after adjustment for age, smoking, social class, physical activity, alcohol intake, systolic blood pressure, antihypertensive treatment, diabetes, and preexisting ischemic heart disease. Relative risk in the low third (< 3.10 L) versus high third (> 3.65 L) was 1.4 (95% confidence interval, 1.0 to 2.0). The inverse association between FEV1 and stroke was only apparent in older men, current nonsmokers, hypertensive men, and men with preexisting ischemic heart disease. Lower FEV1 was associated with higher rates of stroke in hypertensive men irrespective of smoking status. Inclusion of FEV1 in a risk score for stroke provided only a small increase in the absolute risk or the yield of cases in the top fifth of the score distribution during the follow-up period.
CONCLUSIONS: Lower levels of FEV1 are associated with an increased risk of stroke in those already at high risk, eg, those with ischemic heart disease or hypertension. However, the association is not strong enough to warrant the use of FEV1 in making clinical decisions regarding the treatment of hypertension as it relates to the prevention of stroke.

Entities:  

Mesh:

Year:  1995        PMID: 7482639     DOI: 10.1161/01.str.26.11.2004

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  12 in total

Review 1.  Toward therapeutic pulmonary alveolar regeneration in humans.

Authors:  Donald Massaro; Gloria Decarlo Massaro
Journal:  Proc Am Thorac Soc       Date:  2006-11

2.  Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung Study.

Authors:  R G Barr; F S Ahmed; J J Carr; E A Hoffman; R Jiang; S M Kawut; K Watson
Journal:  Eur Respir J       Date:  2011-10-27       Impact factor: 16.671

3.  Influence of lung function and sleep-disordered breathing on stroke: a community-based study.

Authors:  J Zhang; Z Gong; R Li; Y Gao; Y Li; J Li; B Yan; G Wang
Journal:  Eur J Neurol       Date:  2018-07-18       Impact factor: 6.089

Review 4.  Chronic Obstructive Pulmonary Disease and the Risk of Stroke.

Authors:  Ann D Morgan; Chetna Sharma; Kieran J Rothnie; James Potts; Liam Smeeth; Jennifer K Quint
Journal:  Ann Am Thorac Soc       Date:  2017-05

5.  Asthma and incident cardiovascular disease: the Atherosclerosis Risk in Communities Study.

Authors:  J G Schanen; C Iribarren; E Shahar; N M Punjabi; S S Rich; P D Sorlie; A R Folsom
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

6.  Quantifying Risk Factors for Atrial Fibrillation: Retrospective Review of a Large Electronic Patient Database.

Authors:  Jaclyn Rivington; Patrick Twohig
Journal:  J Atr Fibrillation       Date:  2020-10-31

7.  Peak flow rate and death due to coronary heart disease: 30-year results from the Northwick Park Heart cohort study.

Authors:  Tim C Clayton; Tom W Meade; Elizabeth L Turner; Bianca L De Stavola
Journal:  Open Heart       Date:  2014-10-08

8.  Hypertension, systemic inflammation and body weight in relation to lung function impairment-an epidemiological study.

Authors:  Olof Birna Margretardottir; Sigurdur James Thorleifsson; Gunnar Gudmundsson; Isleifur Olafsson; Bryndis Benediktsdottir; Christer Janson; A Sonia Buist; Thorarinn Gislason
Journal:  COPD       Date:  2009-08       Impact factor: 2.409

9.  Is there evidence of early vascular disease in patients with obstructive sleep apnoea without known comorbidities? Preliminary findings.

Authors:  P Steiropoulos; C Bogiatzi; K Archontogeorgis; E Nena; M Xanthoudaki; P Boglou; A Tzouvelekis; N Papanas; G Tsivgoulis; D Bouros
Journal:  Open Cardiovasc Med J       Date:  2013-08-23

10.  Joint effects of smoking and sedentary lifestyle on lung function in African Americans: the Jackson Heart Study cohort.

Authors:  Brenda W Campbell Jenkins; Daniel F Sarpong; Clifton Addison; Monique S White; Demarc A Hickson; Wendy White; Cecil Burchfiel
Journal:  Int J Environ Res Public Health       Date:  2014-01-28       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.